360biolabs, acquired by BioAgilytix in 2021, is a leading bioanalytical laboratory services provider headquartered in Melbourne, Australia, with an additional facility in Brisbane. Specializing in supporting pharmaceutical and biotech companies, they offer comprehensive services for clinical trials, focusing on virology, immunology, biomarker analysis, and pharmacokinetics (PK). As part of BioAgilytix, 360biolabs enhances global capabilities in regulated bioanalysis, particularly within the Asia-Pacific region, contributing to the development of novel therapeutics, vaccines, and diagnostic tools.
Serves as the main operational hub and state-of-the-art laboratory for 360biolabs' (now BioAgilytix's) Asia-Pacific bioanalytical services, specializing in virology, immunology, biomarker, and PK/PD testing for all phases of clinical trials.
Advanced BSL-2 and BSL-3 containment laboratories, cutting-edge analytical instrumentation, and co-location with the prestigious Burnet Institute, fostering scientific collaboration and access to world-class research infrastructure. Recently expanded with a new purpose-built facility in Melbourne.
A scientifically driven, quality-focused, and collaborative environment. Employees are dedicated to precision and innovation in supporting critical drug development programs. Integration with BioAgilytix fosters a global teamwork perspective while retaining a strong local scientific identity.
A critical center for specialized bioanalytical services in the Asia-Pacific region, renowned for its expertise in virology and immunology. Its capabilities are vital for supporting local and international clinical trials, contributing significantly to global health advancements.
While 360biolabs' physical laboratories are located in Australia (Melbourne and Brisbane), it serves a global clientele of pharmaceutical and biotechnology companies. As part of BioAgilytix, it is integral to a global network of advanced bioanalytical laboratories with additional sites in North America (Durham, NC; Boston, MA; San Diego, CA - USA) and Europe (Hamburg, Germany). This network allows for globally harmonized services and support for multinational clinical trials.
Burnet Institute, 85 Commercial Road
Melbourne
Victoria
Australia
Address: QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD 4006, Australia
Supports clinical trials and research initiatives primarily in Queensland and Northern Australia, leveraging its co-location with the QIMR Berghofer Medical Research Institute for access to specialized resources and collaborative opportunities.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 360biolabs, a BioAgilytix company' leadership includes:
360biolabs, a BioAgilytix company has been backed by several prominent investors over the years, including:
Following its acquisition by BioAgilytix in 2021, the original 360biolabs leadership team transitioned into key executive roles within BioAgilytix's APAC operations. Executive movements within the last 12 months would typically be reported under BioAgilytix corporate announcements. No specific executive changes directly branded under '360biolabs' have been publicly highlighted in the past year.
Discover the tools 360biolabs, a BioAgilytix company uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Historically, 360biolabs used email formats like [first_initial][last]@360biolabs.com. Since the acquisition by BioAgilytix, current communications and official email addresses for personnel are typically under the @bioagilytix.com domain (e.g., firstname.lastname@bioagilytix.com). Emails to the legacy @360biolabs.com domain may no longer be actively monitored or may have low deliverability.
flast@360biolabs.com (historical)
Format
jdoe@360biolabs.com
Example
10%
Success rate
BioAgilytix Official Website • April 18, 2024
BioAgilytix has officially opened its new, purpose-built 6,500 m² (69,000 ft²) bioanalytical laboratory in Melbourne, Australia. This facility significantly expands the capacity and capabilities previously established by 360biolabs, reinforcing BioAgilytix's commitment to serving the APAC region with advanced bioanalytical services for biologics, cell and gene therapies, and vaccines....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 360biolabs, a BioAgilytix company, are just a search away.